One analyst said profit taking by long-term holders spiked meaningfully into the $73,000 level and has cooled down in recent weeks, supporting a bullish bias in the future.Markets, news, Trading, Markets, InvestRead More

You might also be interested in reading Earnings Snapshot: AstraZeneca core EPS surpasses estimates with strong Q4 results; initiates FY outlook.